GENE THERAPY

    Gene therapy is a treatment method for hereditary disorders in which genes containing faults (= mutations) found in patients are replaced with healthy copies or these healthy copies are added to cells containing faults. The replacement genes produce again the proteins that as a result of the mutations were no longer produced. This should stop the deterioration of the functioning of the retina or cochlea. 

    GENE THERAPY STUDY FOR USHER

    Various research institutes are doing studies into gene therapy for Usher Syndrome. Gene therapy is really promising and the developments are going quite fast.
    We have an overview of all studies into gene therapy for the various Usher genes.

    GENE THERAPY FOR EYE DISEASES

    An important advantage of gene therapy for Usher Syndrome is that the retina can be reached with one syringe and the AVV vector can be applied very locally and specifically. Besides, only a small quantity is needed. Another advantage is that the immune system in the eye is less responsive. This reduces the chance of an immune response and infection that would block the effect of the treatment.

    Research has shown that after gene therapy, the retina (part of the eye) can despite the presence of dead cells make normal connections with other cells, which leads to a normal response to light.

    Also take a look at the fact sheet about gene therapy of the Life Sciences and Society Foundation (BWM = Biowetenschappen en Maatschappij). (Unfortunately only in Dutch)

    A VIRUS AS A MEANS OF TRANSPORT

    With this therapy a healthy copy of a required gene is delivered at a specific place in the body, for instance the eye. This is usually done with the help of a molecular vehicle or means of transport: a virus. Not any virus can simply be used as a means of transport. A suitable virus is first deactivated, so that it cannot multiply itself and cause any other disease. This type of virus is called a vector, a kind of ‘packaging’. Then the required gene is inserted into the DNA of the virus. Finally, the vector with its new content is injected into a certain area in the eye, after which the new gene in the particular cells are translated into a functional protein. The most commonly used vector is the adeno-associated viral vector (AAV). 

    A MODEL FOR TESTING

    Researchers have to work with cell strings and animal models expressing the Usher genes. These are really hard to find. For example, mice have hardly any problems with their eyesight even when they have an Usher gene. For the time being, the zebrafish seems to be the best animal model that can be measured for both deafness and blindness.

    IT’S IN THE PROTEINS

    The proteins control all processes in our bodies. These proteins are built using codes that have been captured in the DNA. Due to a writing error in the DNA a protein can be produced incorrectly or not at all. Fixing this DNA error changes the production of the protein and so makes the disorder disappear or reduces the symptoms. This is the idea behind the genetic therapies that are now under development throughout the world.